Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Comparing SpO2 targets and oximeters during high-flow nasal oxygen

Official title: Comparison of Two SpO2 Targets With Two Different Oximeters - Impact on FiO2 During Nasal High Flow Oxygen Therapy

Run by Laval University · NCT07168213 · Data updated 2026-11-12

This study tests whether two different pulse oximeters (Nonin and Philips) and two SpO2 targets (90% vs 94%) change the amount of oxygen (FiO2) set for adults in the ICU receiving high-flow nasal oxygen.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment30 (estimated)
SponsorLaval University
Academic / other
Locations1 site (Québec, Quebec)
StatusRecruiting
StartedOctober 21, 2025
Main results expectedJune 2027
Study endsDecember 2027
Registry record updatedMarch 9, 2026
Trial IDNCT07168213 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (≥18) admitted to the ICU who are on high-flow nasal oxygen, have an arterial catheter, and have SpO2 between 88% and 100% with FiO2 between 40% and 80% fit this study.

Probably not a fit

Patients without an arterial catheter, without a usable SpO2 signal, with significant methemoglobinemia, in isolation, or expected to need NIV or mechanical ventilation within two hours are unlikely to participate or benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The trial compares two commercial pulse oximeters (Nonin and Philips) and two SpO2 targets (90% and 94%) to see how they affect the fraction of inspired oxygen (FiO2) set during high-flow nasal oxygen therapy. Each enrolled patient undergoes four randomized 10-minute periods covering every oximeter-target combination while clinicians manually titrate FiO2 to the displayed SpO2. Arterial blood gas is collected at the end of each period to measure actual oxygenation. The study is conducted in adult ICU patients who already have an arterial catheter and are receiving high-flow nasal oxygen.

Why it matters

Potential benefit: If successful, the results could help clinicians choose oximeters and SpO2 targets that avoid unnecessary over- or under-oxygenation and improve safe oxygen dosing.

How similar studies have gone: Previous work has shown that oximeter brand and skin pigmentation can change SpO2 readings, but the downstream effect of those differences on FiO2 settings during high-flow nasal oxygen is not well studied.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* ≥ 18 years of age
* Admiitted in intensive care unit
* Presence of an arterial catheter
* Ongoing on high flow nasal oxygen therapy with SpO2 between 88 and 100% with a FiO2 between 40 and 80% with the usual oximeter .

Exclusion Criteria:

* No SpO2 signal with oximeter in use
* False nails or nail polish
* Methemoglobinemia \>0.015 on last available arterial gas
* Patient in isolation (multi-resistant bacteria, C-Difficile, SARS-CoV-2 ...)
* Expected to use another respiratory support within two hour of inclusion (NIV or mechanical ventilation)

Where it's running

  • Institut universitaire de cardiologie et de pneumologie de Québec - Université Laval
    Québec, Quebec, Canada
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.